Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 6 pages · Chinese
Shanghai MicuRx Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai MicuRx Pharmaceutical
- Announcement on Expiration of Shareholding Reduction Plan of Shareholder and Results of Shareholding Reduction
- Announcement on Expiration of Shareholding Reduction Plan of Shareholder and Results of Shareholding Reduction and Change in Equity Reaching 1% Scale
- Announcement on Resolutions of the 27th Meeting of the 2nd Board of Directors
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Postponing Some Investment Projects Financed by Raised Funds
Later from Shanghai MicuRx Pharmaceutical
- Announcement on Shareholding Reduction Plan for Shareholders
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
- Announcement on Resignation of Securities Affairs Representative
- Announcement on Continued Use of Idle Raised Funds for Cash Management
Follow Shanghai MicuRx Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai MicuRx Pharmaceutical